Biomarkers of Breast Cancer
Journal: International Journal of Science and Research (IJSR) (Vol.11, No. 1)Publication Date: 2022-01-05
Authors : Ishant Sharma; Abhilash Singh;
Page : 1134-1136
Keywords : ovarian tumors; benign; malignant; clinical profile;
- Secure Modern Healthcare System Based on Internet of Things and Secret Sharing of IoT Healthcare Data
- An Outlook on India's Healthcare System with a Medical Case Study and Review on Big Data and its Importance in Healthcare
- An Effective Data Management Framework for Healthcare: Big Data Perspective: A Review
- A Novel Approach of Data Driven Analytics for Personalized Healthcare through Big Data
- Big Data in Healthcare
Abstract
Introduction: Breast cancer treatment has experienced several changes in the past decades due to the discovery of specific prognostic and predictive biomarkers that enable the application of more individualized therapies to different molecular subgroups. This study determined biomarkers of breast cancer. Material and methods: This was a hospital based cross sectional observational study conducted for one year from 1st June 2019 to 31st May 2020 in the Department of Pathology, Indira Gandhi Medical College, Shimla. Results: 31 (60.8%) cases were ER positive and 20 (39.2%) were ER negative as per Allred Scoring. In our study, 28 (54.9%) cases were PR positive and 23 (45.1%) were PR negative as per Allred Scoring. Conclusion: Assessment of ER and PR is important for prognosis.
Other Latest Articles
- A Brief Review on Thermoelectric Materials and their Applications
- Spectrum of Cervical Lesion in Papanicolaou Smears Examination in a Tertiary Care Hospital
- Chemical Composition of the Leaves of Four Wild Plants Eaten as Vegetables in Kisangani (DR Congo)
- Influence of Information Technology on Insurance Industry in New Century
- The Role of MRI in the Diagnostic Approach to Spinal Cord Compression
Last modified: 2022-02-15 19:04:11